MKTXS is moving to new location

MKTXS has recently moved to a new location to accommodate the company’s evolving services and team needs. This will be the fourth move in the last 11 years since the company was started by Sandip Shah, current president of MKTXS. Since then, MKTXS has experienced a sturdy growth in personnel and capabilities, highlighted by the launch of our proprietary value platform, MVAP™, which you can learn more about here.

ISPOR Boston, USA Sandip Shah, MKTXS (May 22-24, 2017)

Join us at 22nd annual ISPOR conference in Boston may 22-24 2017.

MKTXS will be presenting the following posters:

 

  • Use of Intermediate Clinical Endpoints (ICE) as a primary efficacy endpoint in malignant melanoma

    RESEARCH POSTER PRESENTATIONS – SESSION V
    PRM: RESEARCH ON METHODS
    Wednesday, May 24, 2017
    8:00 AM – 1:30 PM

    Poster Author Discussion Hour: 12:30 PM – 1:30 PM

  • Targeted literature review of adherence to therapies in Cystic Fibrosis (CF)

    RESEARCH POSTER PRESENTATIONS – SESSION III
    PRS: RESPIRATORY-RELATED DISORDERS
    Tuesday, May 23, 2017
    8:30 AM – 2:00 PM

    Poster Author Discussion Hour: 1:00 PM – 2:00 PM

  • Clinical and economic assessment of Diffuse Large B-Cell Lymphoma (DLBCL) therapies using a proprietary Value Assessment Platform

    RESEARCH POSTER PRESENTATIONS – SESSION II
    PCN: CANCER
    Monday, May 22, 2017
    3:45 PM – 7:45 PM

    Poster Author Discussion Hour: 6:45 PM – 7:45 PM

  • Clinical and humanistic burden and unmet needs in Duchenne Muscular Dystrophy

    RESEARCH POSTER PRESENTATIONS – SESSION III
    PND: NEUROLOGICAL DISORDERS
    Tuesday, May 23, 2017
    8:30 AM – 2:00 PM

    Poster Author Discussion Hour: 1:00 PM – 2:00 PM

  • Burden of Merkel Cell Carcinoma: A Targeted Literature Review

    RESEARCH POSTER PRESENTATIONS – SESSION II
    PCN: CANCER
    Monday, May 22, 2017
    3:45 PM – 7:45 PM

    Poster Author Discussion Hour: 6:45 PM – 7:45 PM

  • Conceptualization of an excel-based Indication-Specific Pricing (ISP) model to assess potential savings to a U.S. Health plan

    RESEARCH POSTER PRESENTATIONS – SESSION II
    PCN: CANCER
    Monday, May 22, 2017
    3:45 PM – 7:45 PM

    Poster Author Discussion Hour: 6:45 PM – 7:45 PM

  • Economic and clinical burden of Acquired Hemophilia (AH) among hospitalized patients in the US using Healthcare Cost and Utilization Project (HCUP)

    RESEARCH POSTER PRESENTATIONS – SESSION III
    PSY: SYSTEMIC DISORDERS/CONDITIONS
    Tuesday, May 23, 2017
    8:30 AM – 2:00 PM

    Poster Author Discussion Hour: 1:00 PM – 2:00 PM

  • Age-specific economic burden of Respiratory Syncytial Virus (RSV) hospitalizations in the United States, 2009-2013: an analysis of Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS)

    RESEARCH POSTER PRESENTATIONS – SESSION I
    PIN: INFECTION
    Monday, May 22, 2017
    8:30 AM – 2:00 PM

    Poster Author Discussion Hour: 1:00 PM – 2:00 PM

  • Identifying the highest business opportunity for future development among key patient subgroups in Non-Small Cell Lung Cancer (NSCLC)

    RESEARCH POSTER PRESENTATIONS – SESSION II
    PCN: CANCER
    Monday, May 22, 2017
    3:45 PM – 7:45 PM

    Poster Author Discussion Hour: 6:45 PM – 7:45 PM